−0.02 USD
−989.80 K USD
0.00 USD
18.41 M
About Vicapsys Life Sciences, Inc.
Sector
Industry
CEO
Federico Luis Pier
Website
Headquarters
Suwanee
Founded
1996
ISIN
US92560A1060
FIGI
BBG000C5W9D5
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. Its product name VICAPSYN is the firm's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The firm's lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company was founded on December 26, 1996 and is headquartered in Suwanee, GA.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VICP is 1.77 USD — it has increased by 39.37% in the past 24 hours. Watch Vicapsys Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Vicapsys Life Sciences, Inc. stocks are traded under the ticker VICP.
VICP reached its all-time high on Jun 12, 1998 with the price of 35,876.03 USD, and its all-time low was 0.000001 USD and was reached on Dec 10, 2024. View more price dynamics on VICP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VICP stock is 28.25% volatile and has beta coefficient of 1.63 M. Track Vicapsys Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Vicapsys Life Sciences, Inc. there?
Today Vicapsys Life Sciences, Inc. has the market capitalization of 57.30 M, it has decreased by −48.16% over the last week.
Yes, you can track Vicapsys Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
VICP net income for the last quarter is −181.43 K USD, while the quarter before that showed −237.13 K USD of net income which accounts for 23.49% change. Track more Vicapsys Life Sciences, Inc. financial stats to get the full picture.
No, VICP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VICP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vicapsys Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vicapsys Life Sciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vicapsys Life Sciences, Inc. stock shows the sell signal. See more of Vicapsys Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.